Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
6260 Sequence Drive
San Diego, CA 92121
September 05, 2013
ITC Nexus Acquires Accumetrics
September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing,...
July 03, 2013
| Dmitriy N. Feldman, M.D., FACC, FSCAI
Hottest Interventional Cardiology Topics of 2013
The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists...
April 16, 2013
Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now...
March 18, 2013
Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
Accumetrics Inc. announced the presentation of a series of important data that solidifies the clinical utility of...
January 04, 2013
VerifyNow II System Gains European CE
Accumetrics Inc. announced that its next generation VerifyNow II System has achieved CE marking for point-of-care...
September 28, 2012
Accumetrics Aligned with Medicare’s Hospital Readmissions Reduction Program
September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use...
August 28, 2012
| Nicole Fornell, Pharm D
Use of Platelet Function Testing — Does it really aid patient management?
Patients with 2C19 that is less active due to loss of gene copies are poor metabolizers of clopidogrel, opening...
May 23, 2012
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection
May 23, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care...
November 11, 2011
ADAPT-DES Registry Finds Higher Stent Thrombosis in High Platelet Reactivity Patients
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT...
June 03, 2011
New CE Marked Prognostic Claim for the VerifyNow Test
June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet...
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions